News & Updates
Filter by Specialty:
Low-dose semaglutide spurs MASLD regression in people with HIV
21 Mar 2024
byJairia Dela Cruz
Treatment with low-dose semaglutide helps reduce the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with HIV, according to data from the single-arm phase IIb ACTG A5371 trial.
Low-dose semaglutide spurs MASLD regression in people with HIV
21 Mar 2024Can’t stress enough: Healthy living prevents T2D
21 Mar 2024
Adherence to a healthy lifestyle, particularly a well-balanced diet, protects against the development of type 2 diabetes (T2D), with differences across ethnicities, suggests a US study.